T-cell immunogenicity and biomarker profiling in advanced melanoma patients receiving the personalized vaccine EVX-01 in combination with pembrolizumab
Dec 12, 2024
Scientific posters
ESMO IO 2024
AI-designed cancer vaccines: antigens from the dark genome are promising cancer vaccine targets
Sep 25, 2024
Scientific posters
ECCB 2024
Advancing Vaccine Development through Precise AI-driven Prediction of Protective Antigens.
Sep 16, 2024
Scientific posters
ESMO 2024
Phase 2 study of AI-designed personalized neoantigen cancer vaccine, EVX-01, in combination with pembrolizumab in advanced melanoma
Jun 4, 2024
Scientific posters
ASCO 2024
Immunogenicity of an AI-designed personalized neoantigen vaccine, EVX-01, in combination with anti-PD1 therapy in patients with metastatic melanoma